Action P09 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Pacific Biosciences of California, Inc. Deutsche Boerse AG

Actions

P09

US69404D1081

Temps réel estimé Tradegate
Autres places de cotation
 19:06:31 17/05/2024 		Varia. 5j. Varia. 1 janv.
1,934 EUR -8,17% Graphique intraday de Pacific Biosciences of California, Inc. +18,82% -77,97%
15/05 Pacific Biosciences et Ambry Genetics sélectionnés pour séquencer jusqu'à 7 000 génomes humains MT
15/05 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. : Morgan Stanley confirme sa recommandation neutre ZM

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Pacific Biosciences, Ambry Genetics Selected to Sequence up to 7,000 Human Genomes
Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
Ambry Genetics and PacBio Announces Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
Pacific Biosciences of California : PacBio Q1 2024 Earnings Presentation
Pacific Biosciences: Q1 Earnings Snapshot
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q1 Revenue $38.8M
Pacific Biosciences of California, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
PacBio Announces First Quarter 2024 Financial Results
NewBiologix Launches Next-Generation Sequencing and Optical Mapping Platform to Drive the Next Wave of Biopharmaceutical Discoveries
Sector Update: Health Care Stocks Higher Late Afternoon
Sector Update: Health Care
Pacific Biosciences of California Q1 Revenue Expected to Be Flat Year Over Year; Guidance Lowered; Shares Sink
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
PacBio Grants Equity Incentive Award to New Employee
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
PacBio Announces PureTarget Repeat Expansion Panel, Expanding Its Portfolio of End-To-End Clinical Research Solutions
PacBio to Present at Upcoming Investor Conferences
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PACB
  4. Action P09
  5. Actualités Pacific Biosciences of California, Inc.
  6. Autres langues